Preface
Preface
Journal of Thoracic Disease
2014;
6
(Suppl 5)
:S488
.
(15 October 2014)
Review Article
Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS)
Journal of Thoracic Disease
2014;
6
(Suppl 5)
:S489-S501
.
(15 October 2014)
Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification
Journal of Thoracic Disease
2014;
6
(Suppl 5)
:S502-S525
.
(15 October 2014)
The new IASLC/ATS/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects
Journal of Thoracic Disease
2014;
6
(Suppl 5)
:S526-S536
.
(15 October 2014)
The revised lung adenocarcinoma classification—an imaging guide
Journal of Thoracic Disease
2014;
6
(Suppl 5)
:S537-S546
.
(15 October 2014)
Validation of the new IASLC/ATS/ERS lung adenocarcinoma classification: a surgeon’s perspective
Journal of Thoracic Disease
2014;
6
(Suppl 5)
:S547-S551
.
(15 October 2014)
The IASLC/ATS/ERS classification of lung adenocarcinoma-a surgical point of view
Journal of Thoracic Disease
2014;
6
(Suppl 5)
:S552-S560
.
(15 October 2014)
The lung adenocarcinoma guidelines: what to be considered by surgeons
Journal of Thoracic Disease
2014;
6
(Suppl 5)
:S561-S567
.
(15 October 2014)
Implementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts
Journal of Thoracic Disease
2014;
6
(Suppl 5)
:S568-S580
.
(15 October 2014)
Reclassification of early stage pulmonary adenocarcinoma and its consequences
Journal of Thoracic Disease
2014;
6
(Suppl 5)
:S581-S588
.
(15 October 2014)
The 2011 IASLC/ATS/ERS pulmonary adenocarcinoma classification: a landmark in personalized medicine for lung cancer management
Journal of Thoracic Disease
2014;
6
(Suppl 5)
:S589-S596
.
(15 October 2014)
Disclosure:
The supplement “New Lung Adenocarcinoma Classification” was commissioned by the editorial office, Journal of Thoracic Disease without any sponsorship or funding. Guibin Qiao served as the unpaid Guest Editor for the supplement.
